FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912943490> ?p ?o ?g. }

• W2912943490 endingPage "2466" @default.
• W2912943490 startingPage "2459" @default.
• W2912943490 abstract "To examine the efficacy and safety of non-ablative vaginal erbium:YAG laser (VEL) for the treatment of overactive bladder syndrome (OAB) compared with those of two other common pharmacotherapies, namely, anticholinergics and β3-adrenoceptor agonists. Female subjects aged 60–69 years who presented with symptoms of OAB from 2015 to 2017 were assigned to three groups (n = 50) receiving treatment with an anticholinergic agent (4 mg fesoterodine), a β3-adrenoceptor agonist (25 mg mirabegron), or VEL (20 min/session of VEL performed thrice). The OAB symptom score (OABSS), Vaginal Health Index Scale (VHIS), and occurrence of adverse effects were examined prior to and at 1 year following treatment initiation. The three groups showed significant improvement (p < 0.001) for all items of the OABSS questionnaire. Improved VHIS scores were observed only in the VEL group. Furthermore, after VEL treatment, a negative correlation was observed between questions 3 (urinary urgency) and 4 (urgency urinary incontinence) of the OABSS and VHIS. Regarding safety, no adverse events were observed in the VEL group. However, subjects in the other two groups complained of constipation, as indicated by the Constipation Assessment Scale scores, and mouth dryness. The therapeutic effects were inadequate for one and two subjects in the VEL and β3-adrenoceptor agonist groups, respectively. VEL safely and effectively improved OABSS through a different mechanism than that involved in pharmacotherapy. We propose the use of VEL as a novel surgical treatment option in the field of urology." @default.
• W2912943490 created "2019-02-21" @default.
• W2912943490 creator A5075064537 @default.
• W2912943490 date "2019-01-28" @default.
• W2912943490 modified "2023-09-30" @default.
• W2912943490 title "Efficacy and safety of non-ablative vaginal erbium:YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and β3-adrenoceptor agonists" @default.
• W2912943490 cites W1497414151 @default.
• W2912943490 cites W1544240983 @default.
• W2912943490 cites W1585934435 @default.
• W2912943490 cites W1607095468 @default.
• W2912943490 cites W1918384836 @default.
• W2912943490 cites W1967312126 @default.
• W2912943490 cites W1968868091 @default.
• W2912943490 cites W1980249609 @default.
• W2912943490 cites W1981940492 @default.
• W2912943490 cites W1986753920 @default.
• W2912943490 cites W2010284170 @default.
• W2912943490 cites W2044661722 @default.
• W2912943490 cites W2061286597 @default.
• W2912943490 cites W2094737423 @default.
• W2912943490 cites W2104349229 @default.
• W2912943490 cites W2158893937 @default.
• W2912943490 cites W2164958589 @default.
• W2912943490 cites W2296118017 @default.
• W2912943490 cites W2509281781 @default.
• W2912943490 cites W2548237106 @default.
• W2912943490 cites W2554333722 @default.
• W2912943490 cites W2585610973 @default.
• W2912943490 cites W2773456308 @default.
• W2912943490 cites W2784783440 @default.
• W2912943490 cites W2793680153 @default.
• W2912943490 cites W2800521692 @default.
• W2912943490 cites W2806119817 @default.
• W2912943490 cites W2847640005 @default.
• W2912943490 cites W2885370194 @default.
• W2912943490 cites W2886986602 @default.
• W2912943490 cites W2887215077 @default.
• W2912943490 cites W2887535210 @default.
• W2912943490 cites W2901283882 @default.
• W2912943490 doi "https://doi.org/10.1007/s00345-019-02644-7" @default.
• W2912943490 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6825634" @default.
• W2912943490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30687908" @default.
• W2912943490 hasPublicationYear "2019" @default.
• W2912943490 type Work @default.
• W2912943490 sameAs 2912943490 @default.
• W2912943490 citedByCount "22" @default.
• W2912943490 countsByYear W29129434902019 @default.
• W2912943490 countsByYear W29129434902020 @default.
• W2912943490 countsByYear W29129434902021 @default.
• W2912943490 countsByYear W29129434902022 @default.
• W2912943490 countsByYear W29129434902023 @default.
• W2912943490 crossrefType "journal-article" @default.
• W2912943490 hasAuthorship W2912943490A5075064537 @default.
• W2912943490 hasBestOaLocation W29129434901 @default.
• W2912943490 hasConcept C126322002 @default.
• W2912943490 hasConcept C126894567 @default.
• W2912943490 hasConcept C14184104 @default.
• W2912943490 hasConcept C142724271 @default.
• W2912943490 hasConcept C170493617 @default.
• W2912943490 hasConcept C197934379 @default.
• W2912943490 hasConcept C204787440 @default.
• W2912943490 hasConcept C2777912814 @default.
• W2912943490 hasConcept C2778164427 @default.
• W2912943490 hasConcept C2778689640 @default.
• W2912943490 hasConcept C2778938600 @default.
• W2912943490 hasConcept C2778941218 @default.
• W2912943490 hasConcept C2781112942 @default.
• W2912943490 hasConcept C42219234 @default.
• W2912943490 hasConcept C71924100 @default.
• W2912943490 hasConceptScore W2912943490C126322002 @default.
• W2912943490 hasConceptScore W2912943490C126894567 @default.
• W2912943490 hasConceptScore W2912943490C14184104 @default.
• W2912943490 hasConceptScore W2912943490C142724271 @default.
• W2912943490 hasConceptScore W2912943490C170493617 @default.
• W2912943490 hasConceptScore W2912943490C197934379 @default.
• W2912943490 hasConceptScore W2912943490C204787440 @default.
• W2912943490 hasConceptScore W2912943490C2777912814 @default.
• W2912943490 hasConceptScore W2912943490C2778164427 @default.
• W2912943490 hasConceptScore W2912943490C2778689640 @default.
• W2912943490 hasConceptScore W2912943490C2778938600 @default.
• W2912943490 hasConceptScore W2912943490C2778941218 @default.
• W2912943490 hasConceptScore W2912943490C2781112942 @default.
• W2912943490 hasConceptScore W2912943490C42219234 @default.
• W2912943490 hasConceptScore W2912943490C71924100 @default.
• W2912943490 hasIssue "11" @default.
• W2912943490 hasLocation W29129434901 @default.
• W2912943490 hasLocation W29129434902 @default.
• W2912943490 hasLocation W29129434903 @default.
• W2912943490 hasOpenAccess W2912943490 @default.
• W2912943490 hasPrimaryLocation W29129434901 @default.
• W2912943490 hasRelatedWork W2027883868 @default.
• W2912943490 hasRelatedWork W2040451989 @default.
• W2912943490 hasRelatedWork W2102743878 @default.
• W2912943490 hasRelatedWork W2331661321 @default.
• W2912943490 hasRelatedWork W2494945167 @default.
• W2912943490 hasRelatedWork W2736206711 @default.
• W2912943490 hasRelatedWork W2746529668 @default.
• W2912943490 hasRelatedWork W3018245904 @default.

• next